According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.57. In 2022 the company made an earnings per share (EPS) of -$2.32 an increase over its 2021 EPS that were of -$3.01.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.60 | -30.72% |
2022 | -$2.32 | -23.11% |
2021 | -$3.01 | -10% |
2020 | -$3.35 | -0% |
2019 | -$3.35 | 1.21% |
2018 | -$3.31 | -32.7% |
2017 | -$4.91 | -19.34% |
2016 | -$6.09 | 54.76% |
2015 | -$3.94 | 1.73% |
2014 | -$3.87 | -16.23% |
2013 | -$4.62 | 91.67% |
2012 | -$2.41 | -31.45% |
2011 | -$3.52 | -27.06% |
2010 | -$4.82 | -43.75% |
2009 | -$8.57 | -57.33% |
2008 | -$20.09 | -82.92% |
2007 | -$117.57 | 20.61% |
2006 | -$97.48 | 175.76% |
2005 | -$35.35 | -21.43% |
2004 | -$44.99 | 100% |
2003 | -$22.50 | -38.24% |
2002 | -$36.42 | 161.54% |
2001 | -$13.93 | -106.46% |
2000 | $215.45 | 2051.55% |
1999 | $10.01 | 839.73% |
1998 | $1.07 | -105.48% |
1997 | -$19.46 | -88.16% |
1996 | -$164.36 |